Ajax Therapeutics

“Abros Therapeutics...agreed to a reverse merger with Werewolf Therapeutics (Nasdaq: HOWL), after having raised $154m from RA Capital Management, Enavate Sciences, and Italy's Abiogen Pharma.”

“Ajax Therapeutics — Cancer drug developer backed by Goldman Sachs Asset Management — Acquired by Eli Lilly for up to $2.3 billion”

“Eli Lilly agreed to acquire Ajax Therapeutics for up to $2.3B.”